Table 4.
PedGenie 2.1 | |||||||||||||
NARAC Study 1a | NARAC Study 2b | Meta-analysis | Previously publishedc | ||||||||||
RA Phenotype | Genotype | OR | 95% CI | pd | OR | 95% CI | pd | OR | 95% CI | pe | OR | 95% CI | p |
RF+ vs. Ctrls. | CT or TT | 1.80 | 1.29–2.49 | <0.001 | 2.34 | 1.82–3.00 | <0.001 | 2.13 | 1.76–2.57 | <0.001 | 2.36 | 1.76–3.16 | <0.001 |
RF- vs. Ctrls. | CT or TT | 1.40 | 0.87–2.27 | 0.20 | 1.08 | 0.71–1.65 | 0.77 | 1.20 | 0.87–1.65 | 0.31 | 1.17 | 0.6–2.31 | 0.64 |
RF+ vs. RF- | CT or TT | 1.07 | 0.58–2.00 | 0.79 | 1.46 | 0.83–2.56 | 0.12 | 1.30 | 0.86–1.95 | 0.18 | |||
Previously publishedf | |||||||||||||
CCP+ vs. Ctrls. | CT or TT | 1.69 | 1.18–2.41 | 0.001 | 2.03 | 1.57–2.62 | <0.001 | 1.90 | 1.55–2.34 | <0.001 | 1.49 | 1.23–1.79 | <0.001 |
CCP- vs. Ctrls. | CT or TT | 1.59 | 1.04–2.45 | 0.035 | 1.41 | 1.03–1.95 | 0.029 | 1.47 | 1.15–1.88 | 0.001 | 1.04 | 0.83–1.29 | 0.40 |
CCP+ vs. CCP- | CT or TT | 1.05 | 0.61–1.80 | 0.93 | 1.16 | 0.83–1.60 | 0.32 | 1.12 | 0.84–1.50 | 0.47 | |||
RF or CCP+ vs. RF-/CCP- | CT or TT | 1.29 | 0.65–2.53 | 0.55 | 1.43 | 0.81–2.52 | 0.06 | 1.38 | 0.89–2.13 | 0.051 | 1.43 | 1.16–1.77 | <0.001 |
aProblem 2 data, 446 family cases and 103 family controls in 202 affected NARAC pedigrees, 664 independent NYC controls; excludes Plenge et al. [6] samples.
bProblem 2 data, samples in Plenge et al. [6] candidate gene file, 839 family cases in 463 pedigrees and 854 independent NYC controls.
cBegovich et al. [3] replication sample (NARAC; 463 independent-sib cases, 926 independent controls), CLR analysis.
dEmpirical confidence intervals and chi-square p-values, 1000 simulations; p < 0.05 in bold.
eEmpirical confidence intervals and CMH chi-square general association test, 1000 simulations; p < 0.05 in bold.
fPlenge et al. [6] first clinical collection, Epidemiological Investigation of RA (EIRA) Swedish cohort (2370 cases 1757 controls); allele association.